Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway

被引:105
作者
Feng, WJ
Webb, P
Nguyen, P
Liu, XH
Li, JD
Karin, M
Kushner, PJ [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit 1119 HSW, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1210/me.15.1.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect 88 activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these coactivators, which are known to mediate AF-1 action.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 88 条
  • [61] Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript:: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
    Razandi, M
    Pedram, A
    Greene, GL
    Levin, ER
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (02) : 307 - 319
  • [62] HER-2/neu signal transduction in human breast and ovarian cancer
    Reese, DM
    Slamon, DJ
    [J]. STEM CELLS, 1997, 15 (01) : 1 - 8
  • [63] ROSEN N, 1986, J BIOL CHEM, V261, P3754
  • [64] Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity
    Saatcioglu, F
    Lopez, G
    West, BL
    Zandi, E
    Feng, WJ
    Lu, HP
    Esmaili, A
    Apriletti, JW
    Kushner, PJ
    Baxter, JD
    Karin, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) : 4687 - 4695
  • [65] SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554
  • [66] Scolnick DM, 1997, CANCER RES, V57, P3693
  • [67] Shibata H, 1997, RECENT PROG HORM RES, V52, P141
  • [68] ONCOGENIC AND TRANSCRIPTIONAL COOPERATION WITH HA-RAS REQUIRES PHOSPHORYLATION OF C-JUN ON SERINE-63 AND SERINE-73
    SMEAL, T
    BINETRUY, B
    MERCOLA, DA
    BIRRER, M
    KARIN, M
    [J]. NATURE, 1991, 354 (6353) : 494 - 496
  • [69] Steroid receptor coactivator-1 is a histone acetyltransferase
    Spencer, TE
    Jenster, G
    Burcin, MM
    Allis, CD
    Zhou, JX
    Mizzen, CA
    McKenna, NJ
    Onate, SA
    Tsai, SY
    Tsai, MJ
    OMalley, BW
    [J]. NATURE, 1997, 389 (6647) : 194 - 198
  • [70] TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
    Takeshita, A
    Cardona, GR
    Koibuchi, N
    Suen, CS
    Chin, WW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) : 27629 - 27634